TherapeuticsMD (TXMD) FCF Margin Growth (3y) (2014 - 2026)
TherapeuticsMD (TXMD) FCF Margin Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.67 Mn | 14.48 Mn | - | 75,532.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 75,532.00 |
| Mar 31, 2026 | 222,654.00 |
| Dec 31, 2025 | 900.00 |
| Sep 30, 2025 | -487,710.00 |
| Jun 30, 2025 | 598,830.00 |
| Mar 31, 2025 | 275,542.00 |
| Dec 31, 2024 | -25,445.00 |
| Sep 30, 2024 | 13,719.00 |
| Jun 30, 2024 | 73,647.00 |
| Mar 31, 2024 | 12,035.00 |
| Dec 31, 2023 | -141,512.00 |
| Sep 30, 2023 | -983,710.00 |
| Jun 30, 2023 | -14,274.00 |
| Mar 31, 2023 | -177,674.00 |
| Dec 31, 2022 | 35,483.00 |
| Sep 30, 2022 | 511,928.00 |
| Jun 30, 2022 | -510,366.00 |
| Mar 31, 2022 | -160,401.00 |
| Dec 31, 2021 | 81,301.00 |
| Sep 30, 2021 | 83,107.00 |